Chinese pharmaceutical company Tasly expanded its activities in Lithuania, the company said in a statement here on Monday.
The company this November began the sale of its premium segment detoxifying teas in Lithuanian pharmacies.
Tasly Group in a statement said it plans to expand in the Baltic country and elsewhere in Europe.
Established in 1994, the group focuses on biological medicine as its core business. The company is on the list of 500 largest pharmaceutical and medical companies in China.
The group's revenues reached 1.75 billion euros (1.88 billion U.S. dollars) in 2014, according to the statement.
